Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04576676 · ClinicalTrials.gov registry record
Environmental Epidemiology of Essential Tremor
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 1,497
- Enrollment target
NCT04576676: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT04576676 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,497 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04576676 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 1,497 participants
- Enrollment target
Study Summary
This study's research is devoted to studying the causes of tremor, and especially essential tremor (ET), which is the most common type of tremor. Previous studies have revealed a link between harmane \[HA\], a dietary neurotoxin, and ET; these studies now also suggest a link between this toxin and Parkinson's disease (PD), a related tremor disorder. Yet these links are tentative rather than conclusively established; therefore, in this new patient-based proposal, which incorporates investigations spanning two continents (North America and Europe), utilizes several complementary study designs (prospective cohort, case control), and draws on several types of tissue (blood, brain), the investigator's goal is to nail down the links between HA and ET and to further solidify the emerging links between HA and PD.
Primary Outcome
Two vials of veinous blood will be collected from each participant and analyzed for the level of harmane. Specimen collection done at the Aston Care Center and sent to Purdue University for analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,497 participants |
| Start Date | 2020-07-02 |
| Est. Completion | 2023-07-19 |
What the finished NCT04576676 record still lists
NCT04576676 is an observational study that tracks outcomes without assigning an intervention. Its 1,497 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04576676 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04576676 about?
NCT04576676 is a clinical study titled "Environmental Epidemiology of Essential Tremor". This study's research is devoted to studying the causes of tremor, and especially essential tremor (ET), which is the most common type of tremor. Previous studies have revealed a link between harmane \[HA\], a dietary neurotoxin, and ET; these studies now also suggest a link between this toxin and P...
What is the current status of trial NCT04576676?
This trial is currently completed. The enrollment target is 1,497 participants. The study started on 2020-07-02. Estimated completion is 2023-07-19.
Who is sponsoring clinical trial NCT04576676?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI